基本資料
種類: ETF
費用比率%: 0.75
資產淨值: 39.22
成立日期: 20/11/2023
 
分析
市值分佈:
86.85%
大市值
1.28%
中市值
--
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:09) 總持有投資項目: 41  
0%
 
100%
     10大 (45.97%)
代號 名稱 佔比% ▼ 持有日期
EWEdwards Lifesciences Corp1.3630/10/2026
REGNRegeneron Pharmaceuticals1.2230/10/2026
TEVATeva Pharmaceutical Industries Limited1.2030/10/2026
MDGLMadrigal Pharmaceuticals1.1130/10/2026
BSXBoston Scientific Corp1.1030/10/2026
BMYBristol-Myers Squibb Co1.0430/10/2026
CHGCFChugai Pharmaceutical Co., Ltd.1.0330/10/2026
DXCMDexCom1.0130/10/2026
CNCCentene Corp0.9530/09/2026
ILMNIllumina0.9130/10/2026
AMGNAmgen0.8530/10/2026
XENEXenon Pharmaceuticals0.5730/09/2026
SRRKScholar Rock Holding Corp0.5530/09/2026
ARWRArrowhead Pharmaceuticals0.5430/10/2026
SONVFSonova Holding AG0.4930/10/2026
MBXMBX Biosciences Inc.0.4830/10/2026
STOKStoke Therapeutics0.4830/09/2026
PODDInsulet Corp0.4730/10/2026
VKTXViking Therapeutics0.4030/10/2026
INSMInsmed Incorporated0.4030/10/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.